The D-alanine content of lipoteichoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model

Neurogastroenterology and Motility

Volumn 20, Issue 7, 2008, Pages 843-850

  Duncker, S C ^a   Wang, L ^a   Hols, P ^b   Bienenstock, J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Colorectal distension; Irritable bowel syndrome; Lactobacillus plantarum; Lipoteichoic acid; Probiotic; Visceral pain perception

Indexed keywords

CYTOKINE; DEXTRO ALANINE; GAMMA INTERFERON; INTERLEUKIN 10; LIPOTEICHOIC ACID; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CELL ACTIVATION; CELL ISOLATION; COLON; COLORECTAL DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; HEART RATE; LACTOBACILLUS PLANTARUM; LYMPHOCYTE; MALE; METHODOLOGY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE; VISCERAL PAIN;

ABDOMINAL PAIN; ALANINE; ANIMALS; COLON; CYTOKINES; DILATATION, PATHOLOGIC; HEART RATE; INFLAMMATION; LACTOBACILLUS PLANTARUM; LIPOPOLYSACCHARIDES; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECTUM; TEICHOIC ACIDS;

EID: 44949093373     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01085.x     Document Type: Article

References (29)

1. Ahn J, Ehrenpreis ED. Emerging treatments for irritable bowel syndrome. Expert Opin Pharmacother 2002 3 : 9 21.
2. Azpiroz F, Bouin M, Camilleri M et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007 19 : 62 88.
3. Tougas G. The nature of pain in irritable bowel syndrome. J Clin Gastroenterol 2002 35 : S26 30.
4. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973 14 : 125 32.
5. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999 44 : 400 6.
6. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006 131 : 445 50.
7. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome Gut 2000 47 : 804 11.
8. Barbara G, Stanghellini V, De GR et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004 126 : 693 702.
9. Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002 122 : 1778 83.
10. Karimi O, Pena AS, van Bodegraven AA. Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: a pilot study. Drugs Today (Barc) 2005 41 : 453 9.
11. Mimura T, Rizzello F, Helwig U et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 53 : 108 14.
12. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001 357 : 1076 9.
13. Dinan TG, Quigley EM, Ahmed SM et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006 130 : 304 11.
14. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005 128 : 541 51.
15. Grangette C, Nutten S, Palumbo E et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A 2005 102 : 10321 6.
16. Kamiya T, Wang L, Forsythe P et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 2006 55 : 191 6.
17. Tougas G, Wang L. Pseudoaffective cardioautonomic responses to gastric distension in rats. Am J Physiol 1999 277 : R272 8.
18. Boughton-Smith NK, Wallace JL, Whittle BJ. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 1988 25 : 115 23.
19. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982 78 : 206 9.
20. Rousseaux C, Thuru X, Gelot A et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007 13 : 35 7.
21. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004 118 : 229 41.
22. de Vos WM. Lipotechoic acid in lactobacilli: D-alanine makes the difference. Proc Natl Acad Sci U S A 2005 102 : 10763 4.
23. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001 13 : 1143 7.
24. Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000 95 : 1231 8.
25. Ho B, Wang L, Tougas G. The neurocardiac response to colonic distension is mediated through sympathovagal neural pathways in rats. Gastroenterology 1996 110 : A679.
26. Lamb K, Zhong F, Gebhart GF, Bielefeldt K. Experimental colitis in mice and sensitization of converging visceral and somatic afferent pathways. Am J Physiol Gastrointest Liver Physiol 2006 290 : G451 7.
27. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL. Cytokine involvement in dynorphin-induced allodynia. Pain 2000 84 : 159 67.
28. Sweitzer S, Martin D, DeLeo JA. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 2001 103 : 529 39.
29. van der Veek PP, van den BM, de Kroon YE, Verspaget HW, Masclee AA. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005 100 : 2510 6.